Callaghan, N, Kenny, RA, O’Neil, B, Crowley, M, Goggin, T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1985; 48: 639–644.
Chen, P, Lin, JJ, Lu, CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. New England Journal of Medicine 2011; 364: 1126–1133.
Johannessen, Landmark C, Patsalos, PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotheropeutics 2010; 10: 119–140.
Marson, AG, Al-Kharusi, AM, Alwaidh, M, et al. SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000–1015.
Mattson, RH, Cramer, JA, Collins, JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study. New England Journal of Medicine 1992; 327: 765–771.
McCormack, M, Alfirevic, A, Bourgeois, S, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine 2011; 364: 1134–1143.
Misra, A, Aggarwal, A, Singh, O, Sharma, S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatric Neurology 2010; 43: 320–324.
Patsalos, PN. Antiepileptic drug interactions – a clinical guide, 3rd edition. Springer, London, UK; 2016.
Patsalos, PN, Berry, DJ, Bourgeois, BFD, Cloyd, JC, Glauser, TA, Johannessen, SI, Leppik, IE, Tomson, T, Perucca, E. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49: 1239–1276.
Patsalos, PN, Froscher, W, Pisani, F, van Rijn, CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002; 43: 365–385.
Patsalos, PN, Perucca, E. Clinically important interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology 2003; 2: 347–356.
Patsalos, PN, Perucca, E. Clinically important interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology 2003; 2: 473–481.
Powell, G, Saunders, M, Rigby, A, Marson, AG. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Cochrane Database Systematic Review 2016; 12:CD007124.
Rambeck, B, Salke-Treumann, A, May, T, Boenigh, HE. Valproic acid induced carbamazepine-10,11-epoxide toxicity in children and adolescents. European Neurology 1990; 30:79–83.